Microglia convert aggregated amyloid-β into neurotoxic forms through the shedding of microvesicles

Cell Death and Differentiation
P JoshiClaudia Verderio

Abstract

Alzheimer's disease (AD) is characterized by extracellular amyloid-β (Aβ) deposition, which activates microglia, induces neuroinflammation and drives neurodegeneration. Recent evidence indicates that soluble pre-fibrillar Aβ species, rather than insoluble fibrils, are the most toxic forms of Aβ. Preventing soluble Aβ formation represents, therefore, a major goal in AD. We investigated whether microvesicles (MVs) released extracellularly by reactive microglia may contribute to AD degeneration. We found that production of myeloid MVs, likely of microglial origin, is strikingly high in AD patients and in subjects with mild cognitive impairment and that AD MVs are toxic for cultured neurons. The mechanism responsible for MV neurotoxicity was defined in vitro using MVs produced by primary microglia. We demonstrated that neurotoxicity of MVs results from (i) the capability of MV lipids to promote formation of soluble Aβ species from extracellular insoluble aggregates and (ii) from the presence of neurotoxic Aβ forms trafficked to MVs after Aβ internalization into microglia. MV neurotoxicity was neutralized by the Aβ-interacting protein PrP and anti-Aβ antibodies, which prevented binding to neurons of neurotoxic soluble Aβ species. Th...Continue Reading

References

Nov 20, 1997·The Journal of Biological Chemistry·D M ParesceF R Maxfield
May 23, 2001·Archives of Biochemistry and Biophysics·T ArigaT Miyatake
Jul 3, 2003·Annals of Neurology·Xianlin HanDavid M Holtzman
May 27, 2004·Journal of Peptide Science : an Official Publication of the European Peptide Society·Yann VerdierBotond Penke
May 21, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Fabio BiancoClaudia Verderio
Jul 19, 2005·Nature Neuroscience·Eric M SnyderPaul Greengard
Jul 14, 2006·Proceedings of the National Academy of Sciences of the United States of America·Lawrence RajendranKai Simons
Oct 13, 2006·Biochemistry·Stephan SchillingHans-Ulrich Demuth
Jan 9, 2007·Neurobiology of Disease·Valérie VingtdeuxNicolas Sergeant
Feb 9, 2007·Journal of Neurochemistry·Dominic M Walsh, Dennis J Selkoe
Apr 4, 2007·Neurobiology of Aging·Fernanda G De FeliceWilliam L Klein
Dec 7, 2007·The EMBO Journal·Ivo Cristiano MartinsFrederic Rousseau
Dec 8, 2007·European Biophysics Journal : EBJ·Laura J VellaAndrew F Hill
Jan 4, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Robyn A SharplesAndrew F Hill
Jan 25, 2008·The EMBO Journal·Konstanze F WinklhoferChristian Haass
Sep 5, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Masaru YamamotoTsuneya Ikezu
Oct 31, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·P GonnordJ M Kanellopoulos
Mar 21, 2009·The EMBO Journal·Fabio BiancoClaudia Verderio
Jun 6, 2009·Nature Reviews. Immunology·Clotilde ThéryElodie Segura
Dec 3, 2009·Proteomics·Marco F L LemosAna C Esteves
Jan 21, 2010·Cell·Christina KielLuis Serrano
Mar 18, 2010·Nature Reviews. Neurology·V Hugh PerryClive Holmes
Mar 23, 2010·Nature Neuroscience·Martin FuhrmannJochen Herms
Jun 17, 2010·Journal of Neural Transmission·C Y Daniel Lee, Gary E Landreth
Aug 10, 2010·Cell·Christian Haass, Eckhard Mandelkow
Sep 24, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Arundhati Jana, Kalipada Pahan
Dec 25, 2010·Proteomics. Clinical Applications·Valentina AlbertiniRoberta Ghidoni
Feb 9, 2011·The Journal of Biological Chemistry·Beiyi ShenStephen J Gould
Jul 23, 2011·The American Journal of Pathology·Alberto Serrano-PozoBradley T Hyman
Aug 16, 2011·Journal of Alzheimer's Disease : JAD·Michelle M MielkeConstantine G Lyketsos
Sep 29, 2011·Nature Neuroscience·Marco PrinzRichard M Ransohoff
Nov 22, 2011·Nature Chemical Biology·Jan BieschkeErich E Wanker

❮ Previous
Next ❯

Citations

May 27, 2014·BioMed Research International·Stephanie M SchindlerAndis Klegeris
Mar 6, 2015·International Journal of Molecular Sciences·Pooja JoshiClaudia Verderio
Feb 20, 2016·Nature Reviews. Neuroscience·Vivian BudnikFranz Wendler
Feb 10, 2016·Frontiers in Immunology·Annamaria NigroRoberto Furlan
Feb 24, 2015·Mass Spectrometry Reviews·Gabriella PocsfalviKároly Vékey
Jan 7, 2016·Frontiers in Cellular Neuroscience·Dora Brites, Adelaide Fernandes
Dec 4, 2015·Stem Cell Research & Therapy·Almudena Fuster-MatanzoStefano Pluchino
Apr 12, 2016·Frontiers in Neuroscience·Manuela Basso, Valentina Bonetto
Feb 24, 2015·Frontiers in Cellular Neuroscience·Roman SankowskiSergio Iván Valdés-Ferrer
Apr 16, 2014·Frontiers in Cellular Neuroscience·Matías Sáenz-CuestaDavid Otaegui
May 2, 2016·Neurochemistry International·Tarja MalmKatja M Kanninen
May 14, 2016·Nature Reviews. Neurology·Alexander G ThompsonMartin R Turner
Jul 10, 2016·Journal of Alzheimer's Disease : JAD·Matteo StravalaciMarco Gobbi
Aug 6, 2016·Small GTPases·Christopher TricaricoCrislyn D'Souza-Schorey
Sep 24, 2016·Journal of Alzheimer's Disease : JAD·Michael B DinkinsErhard Bieberich
Oct 9, 2016·Aging Clinical and Experimental Research·F GuerrieroG Ricevuti
Oct 12, 2016·Acta Neuropathologica Communications·Sonia MazzitelliMichela Matteoli
Aug 20, 2014·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·D M PegtelS Amor
Mar 28, 2017·International Journal of Molecular Sciences·Andrea PompaMichele Bellucci
Mar 6, 2018·Journal of Alzheimer's Disease : JAD·Roberta GhidoniLuisa Benussi
Feb 24, 2018·Glia·Caterina RizziAntonino Cattaneo
Nov 19, 2017·Journal of Neurotrauma·Isla HazeltonYvonne Couch
Aug 18, 2018·Chemistry, an Asian Journal·Shai Zilberzwige-Tal, Ehud Gazit
Nov 18, 2018·British Journal of Pharmacology·Zachery MoorePeter J Crack
Feb 7, 2019·Journal of Leukocyte Biology·Shoutang Wang, Marco Colonna
Feb 1, 2019·Journal of Neurochemistry·Michael R NicholsColin K Combs
Aug 20, 2014·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Luigi F Agnati, Kjell Fuxe
Jan 9, 2015·EMBO Reports·Martina GabrielliClaudia Verderio
Sep 24, 2019·Frontiers in Aging Neuroscience·Anne-Laure HemonnotHélène Hirbec
Sep 19, 2018·Biomolecules·Hélène PolletDonatienne Tyteca
Sep 8, 2017·Advanced Healthcare Materials·Tatsuya OsakiRoger D Kamm
Feb 28, 2020·Clinical Interventions in Aging·Qingqing YinXunyao Hou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Endosomes

Dysfunctional endosomal trafficking may be associated with Alzheimer’s disease (AD) pathology. Targeting the endosome may advance treatment options for AD. Here is the latest research on endosomes and AD.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: Microglia

Microglia are a type of glial cell found throughout the brain and spinal cord. Microglia have been found to be associated with Alzheimer's disease development and progression. Here are the latest discoveries pertaining to Alzheimer's disease and microglia.